BTAIVSCMMB• 3 Months (Normalized)
BTAI vs CMMB (BioXcel Therapeutics Inc. vs Chemomab Therapeutics Ltd.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
CMMB Performance $1.67
-1.76%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+1.76 pts
BTAI outperforming by 1.76 percentage points
BTAICMMB
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI CMMB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BTAI Price | BTAI Gain (%) | CMMB Price | CMMB Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $1.67 | -1.76% | - | |
| Sep 28, 2026 | $- | $1.64 | -3.53% | - | |
| Sep 25, 2026 | $- | $2.16 | +27.06% | - | |
| Sep 24, 2026 | $0.04 | -97.42% | $2.20 | +29.41% | -126.83% |
| Sep 23, 2026 | $0.05 | -96.72% | $2.28 | +34.12% | -130.84% |
| Sep 22, 2026 | $0.04 | -96.74% | $2.51 | +47.65% | -144.39% |
| Sep 21, 2026 | $0.06 | -95.51% | $2.48 | +45.88% | -141.39% |
| Sep 18, 2026 | $0.06 | -95.77% | $2.61 | +53.53% | -149.30% |
| Sep 17, 2026 | $0.08 | -94.52% | $2.80 | +64.71% | -159.23% |
| Sep 16, 2026 | $0.07 | -95.12% | $2.65 | +55.88% | -151.00% |
| Sep 15, 2026 | $0.04 | -96.74% | $2.47 | +45.29% | -142.03% |
| Sep 14, 2026 | $0.05 | -96.71% | $2.45 | +44.12% | -140.83% |
| Sep 11, 2026 | $0.05 | -96.28% | $2.58 | +51.76% | -148.04% |
| Sep 10, 2026 | $0.05 | -96.35% | $2.60 | +52.94% | -149.29% |
| Sep 09, 2026 | $0.05 | -96.57% | $2.69 | +58.24% | -154.81% |
Page 1 of 5